Xuejin Zhu

889 total citations
27 papers, 666 citations indexed

About

Xuejin Zhu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xuejin Zhu has authored 27 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xuejin Zhu's work include Cancer, Hypoxia, and Metabolism (6 papers), Cancer, Lipids, and Metabolism (6 papers) and Renal cell carcinoma treatment (5 papers). Xuejin Zhu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Cancer, Lipids, and Metabolism (6 papers) and Renal cell carcinoma treatment (5 papers). Xuejin Zhu collaborates with scholars based in China, United States and Macao. Xuejin Zhu's co-authors include Char‐Chang Lai, Steven J. Burden, Susan E. Thomas, Weide Zhong, Yangjia Zhuo, Junxiang Chen, Dongshan Zhang, Huiling Li, Xudong Xiang and Jian‐Heng Ye and has published in prestigious journals such as Journal of Clinical Oncology, The EMBO Journal and Cancer Research.

In The Last Decade

Xuejin Zhu

26 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xuejin Zhu China	13	466	270	109	90	70	27	666
Delphine Bacq France	10	522 1.1×	151 0.6×	64 0.6×	55 0.6×	48 0.7×	12	888
Ganeshkumar Rajendran United States	12	445 1.0×	227 0.8×	106 1.0×	91 1.0×	19 0.3×	21	689
Alessia Brossa Italy	14	402 0.9×	165 0.6×	68 0.6×	87 1.0×	30 0.4×	22	598
Nakwon Choe South Korea	18	831 1.8×	251 0.9×	52 0.5×	115 1.3×	41 0.6×	30	1.0k
Cristina Nuevo‐Tapioles Spain	14	452 1.0×	196 0.7×	63 0.6×	91 1.0×	27 0.4×	23	664
Noga Gadir United States	10	696 1.5×	186 0.7×	110 1.0×	99 1.1×	16 0.2×	18	871
Bernhard Gess Germany	15	402 0.9×	249 0.9×	66 0.6×	55 0.6×	28 0.4×	21	751
Xinchun Pi United States	15	578 1.2×	179 0.7×	58 0.5×	70 0.8×	39 0.6×	18	818
Christine Neuhaus Germany	14	733 1.6×	169 0.6×	166 1.5×	42 0.5×	44 0.6×	26	899
Natalia Martín-Martín Spain	15	357 0.8×	83 0.3×	68 0.6×	61 0.7×	49 0.7×	22	532

Countries citing papers authored by Xuejin Zhu

Since Specialization

Citations

This map shows the geographic impact of Xuejin Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuejin Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuejin Zhu more than expected).

Fields of papers citing papers by Xuejin Zhu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuejin Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuejin Zhu. The network helps show where Xuejin Zhu may publish in the future.

Co-authorship network of co-authors of Xuejin Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Xuejin Zhu. A scholar is included among the top collaborators of Xuejin Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuejin Zhu. Xuejin Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Deng, Yulin, Zhihao Zou, Wei‐Cheng Tian, et al.. (2025). Metformin inhibits the progression of castration-resistant prostate cancer by regulating PDE6D induced purine metabolic alternation and cGMP / PKG pathway activation. Cancer Letters. 622. 217694–217694. 2 indexed citations

Chen, Sian, et al.. (2025). L-shaped association between the ratio of serum albumin to globulin and the risk of all-cause mortality among adults with kidney stones: a national cohort study. Translational Andrology and Urology. 14(3). 751–763.

Liu, Ren, Zhihao Zou, Lingwu Chen, et al.. (2024). FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2α blockade by facilitating LDHA phosphorylation. Cell Death and Disease. 15(1). 64–64. 29 indexed citations

Han, Zhaodong, Zhenjie Wu, Jian‐Heng Ye, et al.. (2024). Machine learning–based integration develops a stress response stated T cell (Tstr)–related score for predicting outcomes in clear cell renal cell carcinoma. International Immunopharmacology. 132. 112017–112017. 4 indexed citations

Luo, Cheng, Zongren Wang, Bin Wang, et al.. (2024). Bladder-sparing treatment using tislelizumab combined with gemcitabine/cisplatin in selected patients with muscle-invasive bladder cancer: a real-world study. Clinical & Translational Oncology. 26(7). 1759–1767. 3 indexed citations

Ye, Jian‐Heng, Yuanfa Feng, Zhiduan Cai, et al.. (2023). Metformin escape in prostate cancer by activating the PTGR1 transcriptional program through a novel super-enhancer. Signal Transduction and Targeted Therapy. 8(1). 303–303. 12 indexed citations

Liang, Yuxiang, Yingke Liang, Zhihao Zou, et al.. (2022). Tumor Suppressor Role and Clinical Significance of the FEV Gene in Prostate Cancer. Disease Markers. 2022. 1–14. 4 indexed citations

Han, Zhaodong, Rujun Mo, Yuanfa Feng, et al.. (2022). Differential Expression of E2F Transcription Factors and Their Functional and Prognostic Roles in Human Prostate Cancer. Frontiers in Cell and Developmental Biology. 10. 831329–831329. 14 indexed citations

Wang, Yan, Yuxuan Wang, Sheng-Bang Yang, et al.. (2022). EID3 Promotes Cancer Stem Cell‐Like Phenotypes in Osteosarcoma through the Activation of PI3K‐AKT Signaling Pathway. Oxidative Medicine and Cellular Longevity. 2022(1). 5941562–5941562. 5 indexed citations

10.

Zhu, Xuejin, Yangjia Zhuo, Shulin Wu, et al.. (2021). TFEB Promotes Prostate Cancer Progression via Regulating ABCA2-Dependent Lysosomal Biogenesis. Frontiers in Oncology. 11. 632524–632524. 11 indexed citations

11.

Liu, Ren, Yuanfa Feng, Yulin Deng, et al.. (2021). A HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism. Journal of Experimental & Clinical Cancer Research. 40(1). 188–188. 37 indexed citations

12.

Zou, Zhihao, Ren Liu, Yingke Liang, et al.. (2021). Identification and Validation of a PPP1R12A-Related Five-Gene Signature Associated With Metabolism to Predict the Prognosis of Patients With Prostate Cancer. Frontiers in Genetics. 12. 703210–703210. 5 indexed citations

13.

Ye, Jian‐Heng, Zhiduan Cai, Yong Luo, et al.. (2020). GPD1 Enhances the Anticancer Effects of Metformin by Synergistically Increasing Total Cellular Glycerol-3-Phosphate. Cancer Research. 80(11). 2150–2162. 51 indexed citations

14.

Zhang, Hui, Shaoyou Liu, Weimin Dong, et al.. (2020). Down-regulation of ACACA suppresses the malignant progression of Prostate Cancer through inhibiting mitochondrial potential. Journal of Cancer. 12(1). 232–243. 23 indexed citations

15.

Cai, Zhiduan, Yulin Deng, Jian‐Heng Ye, et al.. (2020). <p>Aberrant Expression of Citrate Synthase is Linked to Disease Progression and Clinical Outcome in Prostate Cancer</p>. Cancer Management and Research. Volume 12. 6149–6163. 21 indexed citations

16.

Wang, Juan, Dengke Wu, Yu Zhou, et al.. (2019). lncRNA NR_038323 Suppresses Renal Fibrosis in Diabetic Nephropathy by Targeting the miR-324-3p/DUSP1 Axis. Molecular Therapy — Nucleic Acids. 17. 741–753. 88 indexed citations

17.

Zhong, Weide, Yuxiang Liang, Yingke Liang, et al.. (2019). Tumor Suppressor Role and Clinical Implication of the Fifth Ewing Variant (FEV) Gene, an ETS Family Gene, in Prostate Cancer. SSRN Electronic Journal. 1 indexed citations

18.

Wu, Shulin, Jian‐Heng Ye, Zongwei Wang, et al.. (2018). Expression of aromatase in tumor related stroma is associated with human bladder cancer progression. Cancer Biology & Therapy. 19(3). 175–180. 12 indexed citations

19.

Wang, Juan, Jian Pan, Huiling Li, et al.. (2018). lncRNA ZEB1-AS1 Was Suppressed by p53 for Renal Fibrosis in Diabetic Nephropathy. Molecular Therapy — Nucleic Acids. 12. 741–750. 77 indexed citations

20.

Zhuo, Yangjia, Yu Zheng, Rujun Mo, et al.. (2017). High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer. International Urology and Nephrology. 49(5). 817–823. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact